Effect of chrysin and natural coumarins on UGT1A1 and 1A6 activities in rat and human hepatocytes in primary culture

Planta Medica

Volumn 73, Issue 8, 2007, Pages 742-747

  Chlouchi, Amina ^a   Girard, Corinne ^a   Bonet, Alexandre ^a   Viollon Abadie, Catherine ^a,b,c   Heyd, Bruno ^b   Mantion, Georges ^b   Martin, Hélène ^a   Richert, Lysiane ^a,b,c  

^a UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^b UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^c KaLy Cell   (France)

Author keywords

Avicennin; Bergapten; Chrysin; cis avicennol; Coumarins; Hepatocytes; Imperatorin; Rutaceae; UGT1A1; UGT1A6; Umbelliferone

Indexed keywords

AVICENNIN; AVICENNOL; BERGAPTEN; BETA NAPHTHOFLAVONE; CHRYSIN; CLOFIBRIC ACID; COUMARIN; FUROCOUMARIN; GLUCURONOSYLTRANSFERASE 1A1; GLUCURONOSYLTRANSFERASE 1A6; NITROPHENOL; PENTOSALEN; PHENOBARBITAL; PYRANOCOUMARIN DERIVATIVE; UMBELLIFERONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INDUCTION; GLUCURONIDATION; HUMAN; HUMAN CELL; LIVER CELL CULTURE; NONHUMAN; RAT; REGULATORY MECHANISM;

ANIMALS; COUMARINS; FLAVONOIDS; GLUCURONOSYLTRANSFERASE; HEPATOCYTES; HUMANS; MICROSOMES, LIVER; PHYTOTHERAPY; RATS; RUTACEAE;

RATTUS; RUTACEAE;

EID: 34547763822     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-981548     Document Type: Article

References (26)

1. Tukey RH. Human UDP-glucuronosylltransferases: metabolism, expression and disease. Annu Rev Pharmacol Toxicol 2000; 40: 581-616. 2 Tephly TR, Burchell B. UDP-glucuronosyltransferases: a family of detoxifying enzymes. Trends Pharmacol Sci 1990; 11: 276-9.
2. Embola CW, Sohn OS, Fiala ES, Weisburger JH. Induction of UDP-glucuronosyltransferase 1 (UDP-GT1) gene complex by green tea in male F344 rats. Food Chem Toxicol 2002; 40: 841-4.
3. Van der Logt EMJ, Roelofs HMJ, Nagengast FM, Peters WHM. Induction of rat hepatic and intestinal UDP-glucuronyltransferases by naturally occuring dietary anticarcinogens. Carcinogenesis 2003; 24: 1651-6.
4. Walle UK, Walle T. Induction of human UDP-glucuronosyltransferase UGT1A1 by flavonoids - structural requirements. Drug Metab Dispos 2002; 30: 564-9.
5. Moon YJ, Wang X, Morris ME. Dietary flavonoids: effect on xenobiotic and carcinogen metabolism. Toxicol In Vitro 2006; 20: 187-210.
6. Rosselli S, Maggio A, Bellone G, Formisano C, Basile A, Cicala C et al. Antibacterial and anticoagulant activities of coumarins isolated from the flowers of Magydaris tomentosa. Planta Med 2007; 73: 103-9.
7. Hoult JRS, Paya M. Pharmacological and biochemical actions of simple coumarins: Natural products with therapeutic potentiel. Gen Pharmacol 1996; 27: 713-22.
8. Roux D, Muyard F, Girard C, Colombain M, Tillequin F, Waterman PG et al. Phebaclavin I, a novel 3-prenylated coumarin, and trichoclin acetate, a new natural furocoumarin, from the aerial parts of Phebalium aff. tuberculosum (Rutaceae). Nat Prod Res 2006; 20: 279-83.
9. Girard C, Roux D, Muyard F, Colombain M, Bévalot F, Tillequin F et al. Three new 3-substituted coumarins from the twigs of Rhadinothamnus rudis ssp. amblycarpus (Phebalium rude ssp. amblycarpum) (Rutaceae). Z Naturforsch [B] 2005; 60: 561-4.
10. Girard C, Muyard F, Colombain M, Tillequin F, Waterman PG, Bévalot F. Coumarins from Phebalium aff. brachycalyx. Biochem Syst Ecol 2005; 33: 1195-201. 12 Chlouchi A, Girard C, Bévalot F, Tillequin F, Waterman PG, Muyard F. Coumarins and furoquinoline alkaloids from Philotheca deserti var. deserti (Rutaceae). Biochem Syst Ecol 2006; 34: 71-4.
11. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 1987; 47: 936-42.
12. Binda D, Lasserre-Bigot D, Bonet A, Thomassin M, Come M P, Guinchard C et al. Time course of cytochromes P450 decline during rat hepatocyte isolation and culture: effect of L-NAME. Toxicol In Vitro 2003; 17: 59-67.
13. David P, Viollon C, Alexandre E, Azimzadeh A, Nicod L, Wolf P et al. Metabolic capacities in cultured human hepatocytes obtained by a new isolating procedure from non-wedge small liver biopsies. Hum Exp Toxicol 1998; 17: 544-53.
14. Chesné C, Guyomard C, Fautrel A, Poulain MG, Frémond B, De Jong H et al. Viability and function in primary culture of adult hepatocytes from various animal species and human beings after cryopreservation. Hepatology 1993; 18: 406-14.
15. Richert L, Binda D, Hamilton G, Viollon-Abadie C, Alexandre E, Bigot-Lasserre D et al. Evaluation of the effect of culture configuration on morphology, survival time, antioxidant status and metabolic capacities of cultured rat hepatocytes. Toxicol In Vitro 2002; 16: 89-99.
16. Viollon-Abadie C, Lasserre D, Debruyne E, Nicod L, Carmichael N, Richert L. Phenobarbital, β-naphtoflavone, clofibrate, and pregnenolone-16α- carbonitrile do not affect hepatic thyroid hormone UDP-glucuronosyltransferase activity, and thyroid gland function in mice. Toxicol Appl Pharmacol 1999; 155: 1-12.
17. Heirwegh KPM, Van Der Vijver M, Fevery J. Assay and properties of digitonin-activated bilirubin uridine diphosphate glucuronosyltransferase from rat liver. Biochem J 1972; 144: 57-61.
18. Smith PK, Krohn RI, Hermanson GT, Malia AK, Gartner FH, Provenzano MI et al. Measurement of protein using bicinchoninic acid. Anal Biochem 1985; 150: 76-85.
19. Viollon-Abadie C, Bigot-Lasserre D, Nicod L, Carmichael N, Richert L. Effects of model inducers on thyroxine UDP-glucuronosyltransferase activity in vitro rat and mouse hepatocyte cultures. Toxicol In Vitro 2000; 14: 504-12.
20. Galijatovic A, Otake Y, Walle UK, Walle T. Induction of UDP-glucuronyltransferase by the flavonoids chrysin and quercetin in Caco-2 cells-potentiel role in carcinogen bioinactivation. Pharm Res 2001; 18: 374-9.
21. Walle UK, Walle T. Induction of human UDP-glucuronosyltransferase UGT1A1 by flavonoids - structural requirements. Drug Metab Dispos 2002; 30: 564-9.
22. Smith CM, Graham RA, Krol WL, Silver IS, Negishi M, Wang H et al. Differential UGT1A1 induction by chrysin in primary human hepatocytes and HepG2 cells. J Pharmacol Exp Ther 2005; 315: 1256-64.
23. Richert L, Lamboley C, Viollon-Abadie C, Grass P, Hartmann N, Laurent S et al. Effects of clofibric acid on mRNA expression profiles in primary cultures of rat, mouse and human hepatocytes. Toxicol Appl Pharmacol 2003; 191: 130-46.
24. Smith CM, Faucette SR, Wang H, Lecluyse EL. Modulation of UDP-glucuronosyltransferase 1A1 in primary human hepatocytes by prototypical inducers. J Biochem Mol Toxicol 2005; 19: 96-108.
25. Soars MG, Petullo DM, Eckstein JA, Kasper SC, Wrighton SA. An assessment of UDP-glucuronosyltransferase induction using primary human hepatocytes. Drug Metab Dispos 2004; 32: 140-8.
26. Ritter JK, Kessler FK, Thompson MT, Grove AD, Auyeung DJ, Fisher RA. Expression and inducibility in the human bilirubin UGT-Glucuronosyltransferase UGT1A1 in liver and cultured primary hepatocytes: evidence for both genetic and environmental influences. Hepatology 1999; 30: 476-84.